Tanvex Biopharma(TW:6541)
NT$28.15+-0.95 (+1.08%)
TW:6541
Tanvex Biopharma earnings date
NT$28.15
At close:+-0.95 (+1.08%)
Want to see TW:6541 full AI Analyst Report?
Tanvex Biopharma (6541) Earnings Dates, Call Summary & Reports
Earnings Data
- Estimated Report Date
- Nov 16, 2026
- Period Ending
- 2026 (Q3)
- Consensus EPS Forecast
- ―
- Last Year’s EPS
- -1.08
TBA (Not Confirmed)
Same Quarter Last Year
Tanvex Biopharma (TW:6541) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
TW:6541 Q2 2026 Earnings Report
TW:6541 Upcoming Earnings
Tanvex Biopharma's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
TW:6541 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q3) | ―- | -1.08 | ― | ― | ― | ― |
| Aug 12, 2026 | 2026 (Q2) | -1.66-1.44 | -1.43 | -0.98% (-0.01) | ― | ― | |
| May 12, 2026 | 2026 (Q1) | -1.64-1.47 | -2.08 | 29.19% (+0.61) | ― | ― | |
| Mar 04, 2026 | 2025 (Q4) | -0.76-1.60 | -1.68 | 4.88% (+0.08) | ― | ― | |
| Nov 12, 2025 | 2025 (Q3) | ―-1.08 | -1.93 | 43.90% (+0.84) | ― | ― | |
| Aug 12, 2025 | 2025 (Q2) | ―-1.43 | -2.29 | 37.61% (+0.86) | ― | ― | |
| May 07, 2025 | 2025 (Q1) | ―-2.08 | -3.1 | 32.92% (+1.02) | ― | ― | |
| Mar 14, 2025 | 2024 (Q4) | ―-1.68 | -3.8 | 55.73% (+2.12) | ― | ― | |
| Nov 08, 2024 | 2024 (Q3) | ―-1.93 | -3.71 | 48.16% (+1.79) | ― | ― | |
| Aug 09, 2024 | 2024 (Q2) | ―-2.29 | -3.82 | 39.95% (+1.52) | ― | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
TW:6541 Earnings-Related Price Changes
| Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Aug 12, 2026 | NT$38.90 | NT$38.10 | -2.06% |
| May 12, 2026 | NT$39.30 | NT$40.85 | +3.94% |
| Mar 04, 2026 | NT$44.60 | NT$44.80 | +0.45% |
| Nov 12, 2025 | NT$55.30 | NT$55.70 | +0.72% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.
FAQ
When does Tanvex Biopharma (TW:6541) report earnings?
Tanvex Biopharma (TW:6541) is estimated to report earnings on Nov 16, 2026, TBA (Not Confirmed). The date is an estimate based on past reporting schedules and may change.
